A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
NACompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Alovudine
Trial Locations (3)
10021
Mem Sloan - Kettering Cancer Ctr, New York
21287
Johns Hopkins Hosp, Baltimore
275997215
Univ of North Carolina School of Medicine, Chapel Hill
NCT00002254 - A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) | Biotech Hunter | Biotech Hunter